This panel seeks to get to the bottom of the IFR and what it means for the hemp CBD industry currently and in the future. We may also touch on the intersection of USDA and FDA authority to regulate hemp-derived CBD products.
This panel will address current and emerging challenges surrounding such methods and new products from the business, legal, and regulatory perspectives. Topics will include the vaping crisis, regulation of novel delivery systems, hardware inputs and related supply chain matters, various approaches to the regulation of edibles, hemp, and hemp-derived CBD, and what the future may hold.
This CLE will examine equity policy considerations on both the statutory level and the regulatory level, and will inform attorneys and non-attorneys alike what to look for when reading, drafting or recommending policy language, how to engage policy makers and shed light on equity successes, failures and pitfalls to avoid.